KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abbott Laboratories (ABT) EPS (Basic) (2016 - 2025)

Abbott Laboratories (ABT) has disclosed EPS (Basic) for 17 consecutive years, with $1.01 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) fell 80.87% to $1.01 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.73 through Dec 2025, down 51.31% year-over-year, with the annual reading at $3.73 for FY2025, 51.37% down from the prior year.
  • EPS (Basic) hit $1.01 in Q4 2025 for Abbott Laboratories, up from $0.94 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $5.28 in Q4 2024 to a low of $0.59 in Q4 2022.
  • Historically, EPS (Basic) has averaged $1.13 across 5 years, with a median of $0.93 in 2023.
  • Biggest five-year swings in EPS (Basic): soared 473.91% in 2024 and later plummeted 80.87% in 2025.
  • Year by year, EPS (Basic) stood at $1.12 in 2021, then crashed by 47.32% to $0.59 in 2022, then surged by 55.93% to $0.92 in 2023, then skyrocketed by 473.91% to $5.28 in 2024, then tumbled by 80.87% to $1.01 in 2025.
  • Business Quant data shows EPS (Basic) for ABT at $1.01 in Q4 2025, $0.94 in Q3 2025, and $1.02 in Q2 2025.